Literature DB >> 18292799

Molecular mediators of liver ischemia and reperfusion injury: a brief review.

Andrew J Vardanian1, Ronald W Busuttil, Jerzy W Kupiec-Weglinski.   

Abstract

Ischemia and reperfusion injury is a dynamic process that involves multiple organ systems in various clinical states including transplantation, trauma, and surgery. Research into this field has identified key molecular and signaling players that mediate, modulate, or augment cellular, tissue, and organ injury during this disease process. Further elucidation of the molecular mechanisms should provide the rationale to identify much-needed novel therapeutic options to prevent or ameliorate organ damage due to ischemia and reperfusion in clinics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292799      PMCID: PMC2247470          DOI: 10.2119/2007-00134.Vardanian

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  122 in total

Review 1.  Endogenous ligands of Toll-like receptors.

Authors:  Min-Fu Tsan; Baochong Gao
Journal:  J Leukoc Biol       Date:  2004-06-03       Impact factor: 4.962

2.  Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.

Authors:  Jun-ichi Oyama; Charles Blais; Xiaoli Liu; Minying Pu; Lester Kobzik; Ralph A Kelly; Todd Bourcier
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

3.  Tempol, an intracelullar free radical scavenger, reduces liver injury in hepatic ischemia-reperfusion in the rat.

Authors:  B Sepodes; R Maio; R Pinto; C Marques; J Mendes-do-Vale; M C McDonald; C Thiemermann; H Mota-Filipe
Journal:  Transplant Proc       Date:  2004-05       Impact factor: 1.066

4.  A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.

Authors:  William C Goggins; Manuel A Pascual; John A Powelson; Colm Magee; Nina Tolkoff-Rubin; Mary Lin Farrell; Dicken S C Ko; Winfred W Williams; Anil Chandraker; Francis L Delmonico; Hugh Auchincloss; A Benedict Cosimi
Journal:  Transplantation       Date:  2003-09-15       Impact factor: 4.939

5.  P-selectin knockout mice have improved outcomes with both warm ischemia and small bowel transplantation.

Authors:  I C Carmody; L Meng; X D Shen; D Anselmo; F Gao; B Ke; J P Ma; J W Kupiec-Weglinski; S V McDiarmid; R W Busuttil; G Shaw; D G Farmer
Journal:  Transplant Proc       Date:  2004-03       Impact factor: 1.066

6.  The hydroxyl radical scavenger MCI-186 protects the liver from experimental cold ischaemia-reperfusion injury.

Authors:  M Ninomiya; M Shimada; N Harada; Y Soejima; T Suehiro; Y Maehara
Journal:  Br J Surg       Date:  2004-02       Impact factor: 6.939

7.  A new free radical scavenger, edaravone, ameliorates oxidative liver damage due to ischemia-reperfusion in vitro and in vivo.

Authors:  Tomoya Abe; Michiaki Unno; Heigo Takeuchi; Tetsuya Kakita; Yu Katayose; Toshiki Rikiyama; Takanori Morikawa; Masanori Suzuki; Seiki Matsuno
Journal:  J Gastrointest Surg       Date:  2004 Jul-Aug       Impact factor: 3.452

8.  Nitric oxide in early ischaemia reperfusion injury during human orthotopic liver transplantation.

Authors:  Raghu Varadarajan; Lucy Golden-Mason; Leonie Young; Paul McLoughlin; Niamh Nolan; Gerry McEntee; Oscar Traynor; Justin Geoghegan; John E Hegarty; Cliona O'Farrelly
Journal:  Transplantation       Date:  2004-07-27       Impact factor: 4.939

9.  Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction.

Authors:  Yuan-Ji Day; Melissa A Marshall; Liping Huang; Marcia J McDuffie; Mark D Okusa; Joel Linden
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-02       Impact factor: 4.052

10.  Gene therapy for liver transplantation using adenoviral vectors: CD40-CD154 blockade by gene transfer of CD40Ig protects rat livers from cold ischemia and reperfusion injury.

Authors:  Bibo Ke; Xiu-Da Shen; Feng Gao; Ronald W Busuttil; Pedro R Löwenstein; Maria G Castro; Jerzy W Kupiec-Weglinski
Journal:  Mol Ther       Date:  2004-01       Impact factor: 11.454

View more
  55 in total

1.  Interleukin-22: implications for liver ischemia-reperfusion injury.

Authors:  Paul J Chestovich; Yoichiro Uchida; William Chang; Mark Ajalat; Charles Lassman; Robert Sabat; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2012-03-15       Impact factor: 4.939

2.  7,8-dihydroxycoumarin has a dual mechanism of action in hepatic ischemia reperfusion injury.

Authors:  Hai-Yang Zhu; Hong-Wei Gao; Shu-Feng Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 3.  Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis.

Authors:  Anna-Aikaterini Neri; Ismene A Dontas; Dimitrios C Iliopoulos; Theodore Karatzas
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 4.  Current protective strategies in liver surgery.

Authors:  Kurinchi S Gurusamy; Hector D Gonzalez; Brian R Davidson
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

5.  Native macrophages genetically modified to express heme oxygenase 1 protect rat liver transplants from ischemia/reperfusion injury.

Authors:  Xiu-Da Shen; Bibo Ke; Yoichiro Uchida; Haofeng Ji; Feng Gao; Yuan Zhai; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

6.  Sevoflurane Postconditioning Attenuates Hepatic Ischemia-Reperfusion Injury by Limiting HMGB1/TLR4/NF-κB Pathway via Modulating microRNA-142 in vivo and in vitro.

Authors:  Liying Xu; Feng Ge; Yan Hu; Ying Yu; Kefang Guo; Changhong Miao
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

7.  CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model.

Authors:  Yiing Lin; Pamela T Manning; Jianluo Jia; Joseph P Gaut; Zhenyu Xiao; Benjamin J Capoccia; Chun-Cheng Chen; Ronald R Hiebsch; Gundumi Upadhya; Thalachallour Mohanakumar; William A Frazier; William C Chapman
Journal:  Transplantation       Date:  2014-08-27       Impact factor: 4.939

Review 8.  Antioxidant enzyme gene transfer for ischemic diseases.

Authors:  Jian Wu; James G Hecker; Nipavan Chiamvimonvat
Journal:  Adv Drug Deliv Rev       Date:  2009-02-20       Impact factor: 15.470

9.  N-acetylcysteine administration does not improve patient outcome after liver resection.

Authors:  Stuart M Robinson; Rehan Saif; Gourab Sen; Jeremy J French; Bryon C Jaques; Richard M Charnley; Derek M Manas; Steven A White
Journal:  HPB (Oxford)       Date:  2013-01-07       Impact factor: 3.647

10.  Effects of intravenous administration of pentoxifylline in pancreatic ischaemia-reperfusion injury.

Authors:  Edmond Raymond Le Campion; Jose Jukemura; Ana Maria Coelho; Rosely Patzina; Luiz Augusto Carneiro D'Albuquerque
Journal:  HPB (Oxford)       Date:  2012-12-17       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.